Home Newsfeeds Minerva Surgical Says President, CEO To Retire

Minerva Surgical Says President, CEO To Retire

-SEC Filing

byBenzinga Newsdesk

December 28, 2022

1 minute read

-SEC Filing

Tesla Sheds Almost $200B In Market Value Amid Recession Fears And Internal Woes – One-Fifth Of Its Peak Value

By Benzinga Neuro

August 24, 1:34 AM

Following a significant surge in value, Elon Musk’s Tesla Inc. (NASDAQ:TSLA) has lost nearly $200 billion in market capitalization, a fifth…

TSLA

Investor Optimism Declines As Dow Records Weekly Loss

By Lisa Levin

February 13, 3:34 AM

The CNN Money Fear and Greed index showed slight decline in the overall sentiment among US investors. The Dow Jones recorded gains on Friday, but still ended the week down 0.17%. Investors digested recent economic data and earnings reports.

ANET

Cancer Focused Ambrx Biopharma Stock Trading Lower Today – Here’s Why

By Vandana Singh

October 16, 2:00 PM

Ambrx Biopharma Inc (NASDAQ: AMAM) announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic castration-resistant prostate cancer (mCRPC) were made available as part of the 2023 European Society of Medical Oncolog

AMAM

Innodata Stock Soars On Q1 Results, FY24 Guidance

By Erica Kollmann

May 8, 11:05 AM

Innodata reported earnings of 3 cents per share, up from losses of 8 cents per share from the same period last year. Quarterly sales came in at $26.5 million, up from $18.84 million in the prior year's period. The company also raised its guidance to at least 40% organic revenue growth in 2024.

INOD

Minerva Surgical Says President, CEO To Retire

Related Posts

Tesla Sheds Almost $200B In Market Value Amid Recession Fears And Internal Woes – One-Fifth Of Its Peak Value

Investor Optimism Declines As Dow Records Weekly Loss

Cancer Focused Ambrx Biopharma Stock Trading Lower Today – Here’s Why

Innodata Stock Soars On Q1 Results, FY24 Guidance